These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7839081

  • 1. Histamine sensitivity in the nasal mucosa during four-week use of oxymetazoline.
    Graf P, Juto JE.
    Rhinology; 1994 Sep; 32(3):123-6. PubMed ID: 7839081
    [Abstract] [Full Text] [Related]

  • 2. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P, Juto JE.
    ORL J Otorhinolaryngol Relat Spec; 1994 Sep; 56(3):157-60. PubMed ID: 7515487
    [Abstract] [Full Text] [Related]

  • 3. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
    Graf P, Hallén H, Juto JE.
    Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
    [Abstract] [Full Text] [Related]

  • 4. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
    Browning S, Housley D, Richards R, Eccles R.
    Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
    [Abstract] [Full Text] [Related]

  • 5. Nasal hyperreactivity. A histamine provocation model.
    Ohm M, Juto JE.
    Rhinology; 1993 Jun; 31(2):53-5. PubMed ID: 8362169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P, Juto JE.
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
    Graf P, Hallén H, Juto JE.
    Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
    [Abstract] [Full Text] [Related]

  • 13. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
    Graf P, Juto JE.
    ORL J Otorhinolaryngol Relat Spec; 1994 May; 56(6):334-9. PubMed ID: 7530821
    [Abstract] [Full Text] [Related]

  • 14. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR.
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L, Andersson M, Svensson C, Persson CG.
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [Abstract] [Full Text] [Related]

  • 17. Effect of oxymetazoline nose drops on vascular permeability of the nasal mucosa in the rabbit after provocation with leukotriene B4.
    Bende M, Hansell P, Intaglietta M, Arfors KE.
    ORL J Otorhinolaryngol Relat Spec; 1992 Apr; 54(5):270-4. PubMed ID: 1336840
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Time-dependent observations of secretion marker levels in nasal secretion after histamine and methacholine provocations.
    Pupek M, Mikulewicz W, Mielnik J, Batycka B, Katnik-Prastowska I.
    Arch Immunol Ther Exp (Warsz); 2003 Apr; 51(4):259-65. PubMed ID: 12956435
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.